Integer Holdings Corp (ITGR) stock
ITGRNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3022% above fair value
$126.42−0.26 (-0.21%)
Close on Nov 12, 2026Market cap $4.30BP/E 42.4Yield –
Earnings
Integer's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 18, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$450.00M
-3.8% on a year earlier
Non-GAAP adjusted EPS, Q3 FY2026
$1.34
$1.79 a year earlier
Latest guidance
Raised
Apr 30, 2026 · 17 items
Quarterly results
Revenue and earnings per share from each of Integer's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 18, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Oct 2, 2026 | Oct 29, 2026before the open | $450.00M | -3.8% | $0.43 | $1.34 | Release |
| Q2 FY2026ended Jul 3, 2026 | Aug 3, 2026before the open | $464.00M | -2.5% | $0.69 | $1.60 | Release |
| Q1 FY2026ended Apr 3, 2026 | Apr 30, 2026before the open | $440.00M | +0.7% | $0.48 | $1.20 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 19, 2026before the open | $472.00M | +5.1% | $1.38 | $1.76 | Release |
| Q3 FY2025ended Sep 26, 2025 | Oct 23, 2025before the open | $468.00M | +8.6% | $1.11 | $1.79 | Release |
| Q2 FY2025ended Jun 27, 2025 | Jul 24, 2025before the open | $476.00M | +9.2% | $1.04 | $1.55 | Release |
| Q1 FY2025ended Mar 28, 2025 | Apr 24, 2025before the open | $437.00M | +5.3% | -$0.66 | $1.31 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 20, 2025before the open | $449.00M | +8.7% | $0.91 | $1.43 | Release |
| Q3 FY2024ended Sep 27, 2024 | Oct 24, 2024before the open | $431.00M | +6.4% | $1.01 | $1.43 | Release |
| Q2 FY2024ended Jun 28, 2024 | Jul 25, 2024before the open | $436.00M | +9.0% | $0.88 | $1.30 | Release |
| Q1 FY2024ended Mar 29, 2024 | Apr 25, 2024before the open | $415.00M | +9.5% | $0.59 | $1.14 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 15, 2024before the open | $413.00M | – | $0.78 | $1.39 | Release |
| Q3 FY2023ended Sep 29, 2023 | Oct 26, 2023before the open | $405.00M | +18.1% | $0.81 | $1.27 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 27, 2023before the open | $400.00M | +14.3% | $0.71 | $1.14 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 27, 2023before the open | $379.00M | +21.9% | $0.39 | $0.87 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 30, 2023after the close | – | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022before the open | $343.00M | +12.1% | $0.48 | $0.95 | Release |
| Q2 FY2022ended Jul 1, 2022 | Jul 28, 2022before the open | $350.00M | – | $0.62 | $1.04 | Release |
| Q1 FY2022ended Apr 1, 2022 | Apr 28, 2022before the open | $311.00M | – | $0.34 | $0.78 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 17, 2022before the open | $313.00M | – | $0.60 | $0.99 | Release |
| Q3 FY2021ended Oct 1, 2021 | Oct 28, 2021before the open | $306.00M | – | $0.66 | $1.05 | Release |
| Q2 FY2021ended Jul 2, 2021 | Jul 29, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Apr 2, 2021 | Apr 29, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 18, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Oct 2, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Integer's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| SalesGAAP | FY2026 | $1.81B – $1.84B | $1.83B – $1.88B | Lowered | Apr 30, 2026 |
| Sales Change from Prior YearGAAP | FY2026 | -1% – +1% | -2% – +2% | Narrowed | Feb 19, 2026 |
| Operating incomeGAAP | FY2026 | $165.00M – $185.00M | $184.00M – $204.00M | Lowered | Apr 30, 2026 |
| Operating incomenon-GAAP | FY2026 | $285.00M – $305.00M | $304.00M – $324.00M | Lowered | Apr 30, 2026 |
| Operating income Adjusted Change from Prior Yearnon-GAAP | FY2026 | -5% – +1% | -5% – +4% | Lowered | Feb 19, 2026 |
| Operating income Change from Prior YearGAAP | FY2026 | -17% – -8% | – | New | Feb 19, 2026 |
| EBITDAnon-GAAP | FY2026 | $375.00M – $399.00M | $391.00M – $414.00M | Lowered | Apr 30, 2026 |
| EBITDA Adjusted Change from Prior Yearnon-GAAP | FY2026 | -3% – +3% | – | New | Feb 19, 2026 |
| Diluted earnings per shareGAAP | FY2026 | $3.07 – $3.64 | $3.53 – $4.01 | Lowered | Apr 30, 2026 |
| Diluted earnings per share Change from Prior YearGAAP | FY2026 | +22% – +39% | – | New | Feb 19, 2026 |
| Diluted earnings per sharenon-GAAP | FY2026 | $5.83 – $6.40 | $6.29 – $6.78 | Lowered | Apr 30, 2026 |
| Diluted earnings per share Adjusted Change from Prior Yearnon-GAAP | FY2026 | -2% – +6% | -6% – +5% | Raised | Feb 19, 2026 |
| Cash flow from operating activitiesGAAP | FY2026 | $200.00M – $220.00M | – | New | Feb 19, 2026 |
| Cash flow from operating activities Change from Prior YearGAAP | FY2026 | +2% – +12% | – | New | Feb 19, 2026 |
| Capital expenditures | FY2026 | $95.00M – $105.00M | $95.00M – $105.00M | Reaffirmed | Apr 30, 2026 |
| Adjusted effective tax ratenon-GAAP | FY2026 | 16% – 18% | 16% – 18% | Reaffirmed | Apr 30, 2026 |
| Adjusted total interest expensenon-GAAP | FY2026 | $38.00M – $40.00M | $38.00M – $40.00M | Lowered | Apr 30, 2026 |
| Cash flow from operating activitiesGAAP | FY2026 | $185.00M – $205.00M | – | Raised | Apr 30, 2026 |
| Cash income tax payments | FY2026 | $24.00M – $28.00M | $28.00M – $32.00M | Lowered | Apr 30, 2026 |
| Depreciation and amortization | FY2026 | $131.00M – $141.00M | $131.00M – $141.00M | Raised | Apr 30, 2026 |
| Leverage ratio | FY2026 | 2.5 – 3.5 | – | New | Apr 30, 2026 |
| Leverage ratio | FY2026 | 2.5 – 3.5 | – | New | Feb 19, 2026 |
| Net incomeGAAP | FY2026 | $105.00M – $125.00M | $121.00M – $138.00M | Lowered | Apr 30, 2026 |
| Net incomenon-GAAP | FY2026 | $200.00M – $220.00M | – | Raised | Apr 30, 2026 |
| Net income Adjustednon-GAAP | FY2026 | $216.00M – $232.00M | – | New | Feb 19, 2026 |
| Net income Adjusted Change from Prior Yearnon-GAAP | FY2026 | -4% – +3% | – | New | Feb 19, 2026 |
| Net income Change from Prior YearGAAP | FY2026 | +18% – +34% | – | New | Feb 19, 2026 |
| Restructuring, acquisition and other charges | FY2026 | $50.00M – $60.00M | $50.00M – $60.00M | Raised | Apr 30, 2026 |
| Stock-based compensation | FY2026 | $20.00M – $23.00M | $22.00M – $25.00M | Lowered | Apr 30, 2026 |
Guidance vs results
The last range Integer gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Diluted earnings per share Adjusted | $6.29 – $6.43 | $6.41Σ4Q | Within range |
| FY2025 | EPS (GAAP) | $2.70 – $2.84 | $2.87Σ4Q | Above range |
| FY2025 | Revenue | $1.84B – $1.85B | $1.85BΣ4Q | Within range |
| FY2025 | Revenue growth | +7% – +8% | +7.05%Σ4Q | Within range |
| Q4 FY2023 | Revenue | $411.00M – $413.00M | $413.00M | Within range |
Guidance history
Every forecast Integer put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Apr 30, 2026 | Capital expenditures | FY2026 | $95.00M – $105.00M | Reaffirmed |
| Apr 30, 2026 | EBITDA | FY2026 | $375.00M – $399.00M | Lowered |
| Apr 30, 2026 | Diluted earnings per share | FY2026 | $5.83 – $6.40 | Lowered |
| Apr 30, 2026 | Diluted earnings per share | FY2026 | $3.07 – $3.64 | Lowered |
| Apr 30, 2026 | Operating income | FY2026 | $165.00M – $185.00M | Lowered |
| Apr 30, 2026 | Operating income | FY2026 | $285.00M – $305.00M | Lowered |
| Apr 30, 2026 | Leverage ratio | FY2026 | 2.5 – 3.5 | New |
| Apr 30, 2026 | Adjusted effective tax rate | FY2026 | 16% – 18% | Reaffirmed |
| Apr 30, 2026 | Depreciation and amortization | FY2026 | $131.00M – $141.00M | Raised |
| Apr 30, 2026 | Stock-based compensation | FY2026 | $20.00M – $23.00M | Lowered |
| Apr 30, 2026 | Restructuring, acquisition and other charges | FY2026 | $50.00M – $60.00M | Raised |
| Apr 30, 2026 | Cash income tax payments | FY2026 | $24.00M – $28.00M | Lowered |
| Apr 30, 2026 | Net income | FY2026 | $105.00M – $125.00M | Lowered |
| Apr 30, 2026 | Cash flow from operating activities | FY2026 | $185.00M – $205.00M | Raised |
| Apr 30, 2026 | Net income | FY2026 | $200.00M – $220.00M | Raised |
| Apr 30, 2026 | Adjusted total interest expense | FY2026 | $38.00M – $40.00M | Lowered |
| Apr 30, 2026 | Sales | FY2026 | $1.81B – $1.84B | Lowered |
| Feb 19, 2026 | Capital expenditures | FY2026 | $95.00M – $105.00M | New |
| Feb 19, 2026 | EBITDA Adjusted Change from Prior Year | FY2026 | -3% – +3% | New |
| Feb 19, 2026 | EBITDA Adjusted | FY2026 | $391.00M – $414.00M | New |
| Feb 19, 2026 | Diluted earnings per share Adjusted Change from Prior Year | FY2026 | -2% – +6% | Raised |
| Feb 19, 2026 | Diluted earnings per share Adjusted | FY2026 | $6.29 – $6.78 | New |
| Feb 19, 2026 | Diluted earnings per share Change from Prior Year | FY2026 | +22% – +39% | New |
| Feb 19, 2026 | Diluted earnings per share | FY2026 | $3.53 – $4.01 | New |
| Feb 19, 2026 | Cash flow from operating activities Change from Prior Year | FY2026 | +2% – +12% | New |
| Feb 19, 2026 | Cash flow from operating activities | FY2026 | $200.00M – $220.00M | New |
| Feb 19, 2026 | Operating income Change from Prior Year | FY2026 | -17% – -8% | New |
| Feb 19, 2026 | Operating income Adjusted Change from Prior Year | FY2026 | -5% – +1% | Lowered |
| Feb 19, 2026 | Operating income | FY2026 | $184.00M – $204.00M | New |
| Feb 19, 2026 | Operating income Adjusted | FY2026 | $304.00M – $324.00M | New |
| Feb 19, 2026 | Leverage ratio | FY2026 | 2.5 – 3.5 | New |
| Feb 19, 2026 | Adjusted effective tax rate | FY2026 | 16% – 18% | New |
| Feb 19, 2026 | Net income Change from Prior Year | FY2026 | +18% – +34% | New |
| Feb 19, 2026 | Net income Adjusted Change from Prior Year | FY2026 | -4% – +3% | New |
| Feb 19, 2026 | Depreciation and amortization | FY2026 | $131.00M – $141.00M | New |
| Feb 19, 2026 | Stock-based compensation | FY2026 | $22.00M – $25.00M | Lowered |
| Feb 19, 2026 | Restructuring, acquisition and other charges | FY2026 | $50.00M – $60.00M | Raised |
| Feb 19, 2026 | Cash income tax payments | FY2026 | $28.00M – $32.00M | Lowered |
| Feb 19, 2026 | Net income | FY2026 | $121.00M – $138.00M | New |
| Feb 19, 2026 | Net income Adjusted | FY2026 | $216.00M – $232.00M | New |
| Feb 19, 2026 | Adjusted total interest expense | FY2026 | $38.00M – $40.00M | Lowered |
| Feb 19, 2026 | Sales Change from Prior Year | FY2026 | -1% – +1% | Narrowed |
| Feb 19, 2026 | Sales | FY2026 | $1.83B – $1.88B | New |
| Oct 23, 2025 | Capital expenditures | FY2025 | $95.00M – $105.00M | New |
| Oct 23, 2025 | EBITDA Adjusted Change from Prior Year | FY2025 | +10% – +12% | New |
| Oct 23, 2025 | EBITDA Adjusted | FY2025 | $398.00M – $404.00M | New |
| Oct 23, 2025 | Diluted earnings per share Adjusted Change from Prior Year | FY2025 | +19% – +21% | New |
| Oct 23, 2025 | Diluted earnings per share Adjusted | FY2025 | $6.29 – $6.43 | New |
| Oct 23, 2025 | Adjusted EPS | FY2026 | -6% – +5% | New |
| Oct 23, 2025 | Diluted earnings per share Change from Prior Year | FY2025 | -23% – -19% | New |
| Oct 23, 2025 | Diluted earnings per share | FY2025 | $2.70 – $2.84 | New |
| Oct 23, 2025 | Operating income Change from Prior Year | FY2025 | +6% – +9% | New |
| Oct 23, 2025 | Operating income Adjusted Change from Prior Year | FY2025 | +12% – +14% | New |
| Oct 23, 2025 | Operating income | FY2025 | $220.00M – $226.00M | New |
| Oct 23, 2025 | Operating income Adjusted | FY2025 | $319.00M – $325.00M | New |
| Oct 23, 2025 | Adjusted operating income | FY2026 | -5% – +4% | New |
| Oct 23, 2025 | Leverage ratio | FY2025 | 2.7 – 2.8 | New |
| Oct 23, 2025 | GAAP effective tax rate | FY2025 | 21% – 22% | New |
| Oct 23, 2025 | Adjusted effective tax rate | FY2025 | 17% – 18% | New |
| Oct 23, 2025 | Income from continuing operations Change from Prior Year | FY2025 | -20% – -16% | New |
| Oct 23, 2025 | Cash flow from operating activities Change from Prior Year | FY2025 | +12% – +17% | Raised |
| Oct 23, 2025 | Income from continuing operations Adjusted Change from Prior Year | FY2025 | +21% – +24% | New |
| Oct 23, 2025 | Depreciation and amortization of intangible assets | FY2025 | $122.00M – $126.00M | New |
| Oct 23, 2025 | Stock-based compensation | FY2025 | $21.00M – $23.00M | Lowered |
| Oct 23, 2025 | Restructuring, acquisition and other charges | FY2025 | $33.00M – $37.00M | Raised |
| Oct 23, 2025 | Cash income tax payments | FY2025 | $28.00M – $32.00M | Lowered |
| Oct 23, 2025 | Income from continuing operations | FY2025 | $96.00M – $101.00M | New |
| Oct 23, 2025 | Cash flow from operating activities | FY2025 | $230.00M – $240.00M | Raised |
| Oct 23, 2025 | GAAP interest expense | FY2025 | $42.00M – $43.00M | Lowered |
| Oct 23, 2025 | Income from continuing operations Adjusted | FY2025 | $222.00M – $227.00M | New |
| Oct 23, 2025 | Adjusted total interest expense | FY2025 | $41.00M – $42.00M | Lowered |
| Oct 23, 2025 | Sales Change from Prior Year | FY2025 | +7% – +8% | New |
| Oct 23, 2025 | Sales | FY2025 | $1.84B – $1.85B | New |
| Oct 23, 2025 | Reported sales | FY2026 | -2% – +2% | New |
| Jul 24, 2025 | Capital expenditures | FY2025 | $110.00M – $120.00M | Reaffirmed |
| Jul 24, 2025 | EBITDA Adjusted Change from Prior Year | FY2025 | +11% – +16% | Lowered |
| Jul 24, 2025 | EBITDA Adjusted | FY2025 | $402.00M – $418.00M | Narrowed |
| Jul 24, 2025 | Diluted earnings per share Adjusted Change from Prior Year | FY2025 | +18% – +23% | Raised |
| Jul 24, 2025 | Diluted earnings per share Adjusted | FY2025 | $6.25 – $6.51 | Raised |
| Jul 24, 2025 | Diluted earnings per share Change from Prior Year | FY2025 | -20% – -13% | Lowered |
| Jul 24, 2025 | Diluted earnings per share | FY2025 | $2.79 – $3.05 | Lowered |
| Jul 24, 2025 | Operating income Change from Prior Year | FY2025 | +11% – +17% | Lowered |
| Jul 24, 2025 | Operating income Adjusted Change from Prior Year | FY2025 | +12% – +16% | Raised |
| Jul 24, 2025 | Operating income | FY2025 | $232.00M – $244.00M | Lowered |
| Jul 24, 2025 | Operating income Adjusted | FY2025 | $319.00M – $331.00M | Raised |
| Jul 24, 2025 | Leverage ratio | FY2025 | 2.5 – 3.5 | New |
| Jul 24, 2025 | Adjusted effective tax rate | FY2025 | 18.5% – 19.5% | Lowered |
| Jul 24, 2025 | Income from continuing operations Change from Prior Year | FY2025 | -17% – -10% | Lowered |
| Jul 24, 2025 | Cash flow from operating activities Change from Prior Year | FY2025 | +15% – +24% | Raised |
| Jul 24, 2025 | Income from continuing operations Adjusted Change from Prior Year | FY2025 | +21% – +26% | Raised |
| Jul 24, 2025 | Depreciation and amortization | FY2025 | $123.00M – $127.00M | Raised |
| Jul 24, 2025 | Stock-based compensation | FY2025 | $23.00M – $26.00M | Lowered |
| Jul 24, 2025 | Restructuring, acquisition and other charges | FY2025 | $20.00M – $24.00M | Lowered |
| Jul 24, 2025 | Cash income tax payments | FY2025 | $36.00M – $40.00M | Raised |
| Jul 24, 2025 | Income from continuing operations | FY2025 | $100.00M – $109.00M | Raised |
| Jul 24, 2025 | Cash flow from operating activities | FY2025 | $235.00M – $255.00M | Raised |
| Jul 24, 2025 | Income from continuing operations Adjusted | FY2025 | $222.00M – $231.00M | Raised |
| Jul 24, 2025 | Adjusted total interest expense | FY2025 | $40.00M – $42.00M | Lowered |
| Jul 24, 2025 | Sales Change from Prior Year | FY2025 | +8% – +9% | Lowered |
| Jul 24, 2025 | Sales | FY2025 | $1.85B – $1.88B | Narrowed |
| Apr 24, 2025 | Capital expenditures | FY2025 | $110.00M – $120.00M | Reaffirmed |
| Apr 24, 2025 | EBITDA | FY2025 | $401.00M – $422.00M | Reaffirmed |
| Apr 24, 2025 | EBITDA | FY2025 | +11% – +17% | New |
| Apr 24, 2025 | Diluted earnings per share | FY2025 | $6.15 – $6.51 | Raised |
| Apr 24, 2025 | Diluted earnings per share | FY2025 | +16% – +23% | New |
| Apr 24, 2025 | Diluted earnings per share | FY2025 | $3.00 – $3.36 | Lowered |
| Apr 24, 2025 | Diluted earnings per share | FY2025 | -14% – -4% | New |
| Apr 24, 2025 | Operating income | FY2025 | +11% – +16% | New |
| Apr 24, 2025 | Operating income | FY2025 | +16% – +24% | New |
| Apr 24, 2025 | Operating income | FY2025 | $315.00M – $331.00M | Reaffirmed |
| Apr 24, 2025 | Operating income | FY2025 | $242.00M – $258.00M | Reaffirmed |
| Apr 24, 2025 | Income from continuing operations | FY2025 | $108.00M – $120.00M | Lowered |
| Apr 24, 2025 | Cash flow from operating activities | FY2025 | $235.00M – $255.00M | Raised |
| Apr 24, 2025 | Income from continuing operations | FY2025 | $218.00M – $231.00M | Raised |
| Apr 24, 2025 | Adjusted total interest expense | FY2025 | $40.00M – $42.00M | Lowered |
| Apr 24, 2025 | GAAP interest expense | FY2025 | $41.00M – $43.00M | Lowered |
| Apr 24, 2025 | Leverage ratio | FY2025 | 2.5 – 3.5 | New |
| Apr 24, 2025 | full-year GAAP effective tax rate | FY2025 | 26% – 28% | New |
| Apr 24, 2025 | Adjusted effective tax rate | FY2025 | 19% – 21% | Reaffirmed |
| Apr 24, 2025 | Income from continuing operations | FY2025 | -11% – -1% | New |
| Apr 24, 2025 | Cash flow from operating activities | FY2025 | +15% – +24% | Raised |
| Apr 24, 2025 | Income from continuing operations | FY2025 | +19% – +26% | New |
| Apr 24, 2025 | Depreciation and amortization | FY2025 | $114.00M – $124.00M | Raised |
| Apr 24, 2025 | Stock-based compensation | FY2025 | $23.00M – $26.00M | Lowered |
| Apr 24, 2025 | Restructuring, acquisition and other charges | FY2025 | $14.00M – $18.00M | Lowered |
| Apr 24, 2025 | Cash income tax payments | FY2025 | $40.00M – $44.00M | Raised |
| Apr 24, 2025 | Sales | FY2025 | $1.85B – $1.88B | Reaffirmed |
| Apr 24, 2025 | Sales | FY2025 | +8% – +10% | New |
| Feb 20, 2025 | Capital expenditures | FY2025 | $110.00M – $120.00M | New |
| Feb 20, 2025 | EBITDA | FY2025 | $401.00M – $422.00M | New |
| Feb 20, 2025 | Diluted earnings per share | FY2025 | $5.84 – $6.20 | New |
| Feb 20, 2025 | Diluted earnings per share | FY2025 | $4.09 – $4.44 | New |
| Feb 20, 2025 | Operating income | FY2025 | $242.00M – $258.00M | New |
| Feb 20, 2025 | Operating income | FY2025 | $315.00M – $331.00M | New |
| Feb 20, 2025 | Leverage ratio | FY2025 | 2.5 – 3.5 | New |
| Feb 20, 2025 | Adjusted effective tax rate | FY2025 | 19% – 21% | New |
| Feb 20, 2025 | Depreciation and amortization | FY2025 | $114.00M – $124.00M | New |
| Feb 20, 2025 | Stock-based compensation | FY2025 | $23.00M – $26.00M | Lowered |
| Feb 20, 2025 | Restructuring, acquisition and other charges | FY2025 | $14.00M – $18.00M | Lowered |
| Feb 20, 2025 | Cash income tax payments | FY2025 | $40.00M – $44.00M | Raised |
| Feb 20, 2025 | Income from continuing operations | FY2025 | $149.00M – $162.00M | New |
| Feb 20, 2025 | Cash flow from operating activities | FY2025 | $225.00M – $245.00M | Raised |
| Feb 20, 2025 | Income from continuing operations | FY2025 | $208.00M – $221.00M | New |
| Feb 20, 2025 | Adjusted total interest expense | FY2025 | $52.00M – $57.00M | Lowered |
| Feb 20, 2025 | Sales | FY2025 | $1.85B – $1.88B | New |
| Oct 24, 2024 | Capital expenditures | FY2024 | $100.00M – $110.00M | Raised |
| Oct 24, 2024 | EBITDA | FY2024 | $358.00M – $368.00M | Narrowed |
| Oct 24, 2024 | Diluted earnings per share | FY2024 | $5.24 – $5.43 | Narrowed |
| Oct 24, 2024 | Diluted earnings per share | FY2024 | $3.42 – $3.61 | Narrowed |
| Oct 24, 2024 | adjusted operating income outlook | FY2024 | +20% | New |
| Oct 24, 2024 | Operating income | FY2024 | $205.00M – $213.00M | Narrowed |
| Oct 24, 2024 | Operating income | FY2024 | $280.00M – $288.00M | Narrowed |
| Oct 24, 2024 | Leverage ratio | FY2024 | 2.6 – 2.7 | New |
| Oct 24, 2024 | Adjusted effective tax rate | FY2024 | 18% – 19% | Lowered |
| Oct 24, 2024 | organic sales growth | FY2024 | +7% – +8% | New |
| Oct 24, 2024 | Depreciation and amortization | FY2024 | $106.00M – $110.00M | Raised |
| Oct 24, 2024 | Stock-based compensation | FY2024 | $24.00M – $25.00M | Lowered |
| Oct 24, 2024 | Restructuring, acquisition and other charges | FY2024 | $20.00M – $22.00M | Lowered |
| Oct 24, 2024 | Cash income tax payments | FY2024 | $36.00M – $40.00M | Raised |
| Oct 24, 2024 | Income from continuing operations | FY2024 | $122.00M – $128.00M | Lowered |
| Oct 24, 2024 | Cash flow from operating activities | FY2024 | $195.00M – $205.00M | Raised |
| Oct 24, 2024 | Income from continuing operations | FY2024 | $181.00M – $188.00M | Raised |
| Oct 24, 2024 | Adjusted total interest expense | FY2024 | $55.00M – $57.00M | Lowered |
| Oct 24, 2024 | sales growth | FY2024 | +10% – +11% | New |
| Oct 24, 2024 | Sales | FY2024 | $1.71B – $1.73B | Lowered |
| Jul 25, 2024 | Capital expenditures | FY2024 | $90.00M – $110.00M | Reaffirmed |
| Jul 25, 2024 | Adjusted EBITDA | FY2024 | $357.00M – $377.00M | Raised |
| Jul 25, 2024 | Adjusted diluted earnings per share | FY2024 | $5.07 – $5.49 | Raised |
| Jul 25, 2024 | Diluted earnings per share | FY2024 | $3.26 – $3.67 | Lowered |
| Jul 25, 2024 | Operating income | FY2024 | $202.00M – $220.00M | Reaffirmed |
| Jul 25, 2024 | Adjusted operating income | FY2024 | $275.00M – $293.00M | Raised |
| Jul 25, 2024 | Leverage ratio | FY2024 | 2.5 – 3.5 | Reaffirmed |
| Jul 25, 2024 | Adjusted effective tax rate | FY2024 | 18% – 20% | Lowered |
| Jul 25, 2024 | Depreciation and amortization | FY2024 | $106.00M – $114.00M | Raised |
| Jul 25, 2024 | Stock-based compensation | FY2024 | $24.00M – $27.00M | Lowered |
| Jul 25, 2024 | Restructuring, acquisition and other charges | FY2024 | $17.00M – $22.00M | Lowered |
| Jul 25, 2024 | Cash income tax payments | FY2024 | $38.00M – $42.00M | Raised |
| Jul 25, 2024 | Net income | FY2024 | $116.00M – $130.00M | Lowered |
| Jul 25, 2024 | Cash flow from operating activities | FY2024 | $185.00M – $205.00M | Raised |
| Jul 25, 2024 | Adjusted net income | FY2024 | $174.00M – $189.00M | Raised |
| Jul 25, 2024 | Adjusted total interest expense | FY2024 | $58.00M – $61.00M | Lowered |
| Jul 25, 2024 | Sales | FY2024 | $1.74B – $1.77B | Reaffirmed |
| Apr 25, 2024 | Capital expenditures | FY2024 | $90.00M – $110.00M | Reaffirmed |
| Apr 25, 2024 | EBITDA | FY2024 | $355.00M – $375.00M | Reaffirmed |
| Apr 25, 2024 | Diluted earnings per share | FY2024 | $5.01 – $5.43 | Reaffirmed |
| Apr 25, 2024 | Diluted earnings per share | FY2024 | $3.30 – $3.71 | Reaffirmed |
| Apr 25, 2024 | Operating income | FY2024 | $202.00M – $220.00M | Reaffirmed |
| Apr 25, 2024 | Operating income | FY2024 | $272.00M – $290.00M | Reaffirmed |
| Apr 25, 2024 | Leverage ratio | FY2024 | 2.5 – 3.5 | Reaffirmed |
| Apr 25, 2024 | Adjusted effective tax rate | FY2024 | 19% – 21% | Reaffirmed |
| Apr 25, 2024 | Depreciation and amortization | FY2024 | $105.00M – $115.00M | Raised |
| Apr 25, 2024 | Stock-based compensation | FY2024 | $24.00M – $27.00M | Lowered |
| Apr 25, 2024 | Restructuring, acquisition and other charges | FY2024 | $15.00M – $20.00M | Lowered |
| Apr 25, 2024 | Cash income tax payments | FY2024 | $43.00M – $47.00M | Raised |
| Apr 25, 2024 | Net income | FY2024 | $115.00M – $130.00M | Lowered |
| Apr 25, 2024 | Cash flow from operating activities | FY2024 | $185.00M – $205.00M | Raised |
| Apr 25, 2024 | Net income | FY2024 | $171.00M – $185.00M | Raised |
| Apr 25, 2024 | Adjusted total interest expense | FY2024 | $56.00M – $61.00M | Lowered |
| Apr 25, 2024 | Sales | FY2024 | $1.74B – $1.77B | Reaffirmed |
| Feb 15, 2024 | Capital expenditures | FY2024 | $90.00M – $110.00M | New |
| Feb 15, 2024 | EBITDA | FY2024 | $355.00M – $375.00M | New |
| Feb 15, 2024 | Diluted earnings per share | FY2024 | $5.01 – $5.43 | New |
| Feb 15, 2024 | Diluted earnings per share | FY2024 | $3.30 – $3.71 | New |
| Feb 15, 2024 | Operating income | FY2024 | $202.00M – $220.00M | New |
| Feb 15, 2024 | Operating income | FY2024 | $272.00M – $290.00M | New |
| Feb 15, 2024 | Leverage ratio | FY2024 | 2.5 – 3.5 | New |
| Feb 15, 2024 | Adjusted effective tax rate | FY2024 | 19% – 21% | New |
| Feb 15, 2024 | Depreciation and amortization | FY2024 | $105.00M – $115.00M | New |
| Feb 15, 2024 | Stock-based compensation | FY2024 | $24.00M – $27.00M | Lowered |
| Feb 15, 2024 | Restructuring, acquisition and other charges | FY2024 | $15.00M – $20.00M | Lowered |
| Feb 15, 2024 | Cash income tax payments | FY2024 | $43.00M – $47.00M | Raised |
| Feb 15, 2024 | Net income | FY2024 | $115.00M – $130.00M | New |
| Feb 15, 2024 | Cash flow from operating activities | FY2024 | $185.00M – $205.00M | Raised |
| Feb 15, 2024 | Net income | FY2024 | $171.00M – $185.00M | New |
| Feb 15, 2024 | Adjusted total interest expense | FY2024 | $56.00M – $61.00M | Lowered |
| Feb 15, 2024 | Sales | FY2024 | $1.74B – $1.77B | New |
| Jan 10, 2024 | preliminary unaudited sales | Q4 FY2023 | $411.00M – $413.00M | New |
| Jan 10, 2024 | preliminary unaudited sales | FY2023 | $1.60B – $1.60B | New |
| Oct 26, 2023 | Capital expenditures | FY2023 | $100.00M – $120.00M | Reaffirmed |
| Oct 26, 2023 | EBITDA | FY2023 | $302.00M – $310.00M | Raised |
| Oct 26, 2023 | Diluted earnings per share | FY2023 | $4.47 – $4.67 | Raised |
| Oct 26, 2023 | Diluted earnings per share | FY2023 | $2.66 – $2.86 | Raised |
| Oct 26, 2023 | Operating income | FY2023 | $166.00M – $174.00M | Raised |
| Oct 26, 2023 | Operating income | FY2023 | $235.00M – $243.00M | Raised |
| Oct 26, 2023 | Net income | FY2023 | $90.00M – $96.00M | Raised |
| Oct 26, 2023 | Cash flow from operating activities | FY2023 | $185.00M – $205.00M | Raised |
| Oct 26, 2023 | Net income | FY2023 | $151.00M – $157.00M | Raised |
| Oct 26, 2023 | Sales | FY2023 | $1.58B – $1.60B | Raised |
| Jul 27, 2023 | Capital expenditures | FY2023 | $100.00M – $120.00M | Reaffirmed |
| Jul 27, 2023 | Adjusted EBITDA | FY2023 | $294.00M – $302.00M | Raised |
| Jul 27, 2023 | Adjusted diluted earnings per share | FY2023 | $4.23 – $4.43 | Raised |
| Jul 27, 2023 | Diluted earnings per share | FY2023 | $2.45 – $2.65 | Raised |
| Jul 27, 2023 | Operating income | FY2023 | $152.00M – $160.00M | Raised |
| Jul 27, 2023 | Adjusted operating income | FY2023 | $224.00M – $232.00M | Raised |
| Jul 27, 2023 | Leverage ratio | FY2023 | 2.5 – 3.5 | Reaffirmed |
| Jul 27, 2023 | GAAP effective tax rate | FY2023 | 15% – 17% | Reaffirmed |
| Jul 27, 2023 | Adjusted effective tax rate | FY2023 | 17% – 19% | Reaffirmed |
| Jul 27, 2023 | Depreciation and amortization | FY2023 | $100.00M – $105.00M | Raised |
| Jul 27, 2023 | Stock-based compensation | FY2023 | $22.00M – $25.00M | Lowered |
| Jul 27, 2023 | Restructuring, acquisition and other charges | FY2023 | $15.00M – $20.00M | Lowered |
| Jul 27, 2023 | Cash income tax payments | FY2023 | $27.00M – $31.00M | Raised |
| Jul 27, 2023 | Net income | FY2023 | $83.00M – $89.00M | Raised |
| Jul 27, 2023 | Cash flow from operating activities | FY2023 | $185.00M – $205.00M | Raised |
| Jul 27, 2023 | GAAP total interest expense | FY2023 | $49.00M – $55.00M | Lowered |
| Jul 27, 2023 | Adjusted net income | FY2023 | $143.00M – $149.00M | Raised |
| Jul 27, 2023 | Adjusted total interest expense | FY2023 | $45.00M – $50.00M | Lowered |
| Jul 27, 2023 | Sales | FY2023 | $1.53B – $1.55B | Raised |
| Apr 27, 2023 | Capital expenditures | FY2023 | $100.00M – $120.00M | New |
| Apr 27, 2023 | EBITDA | FY2023 | $285.00M – $296.00M | New |
| Apr 27, 2023 | Diluted earnings per share | FY2023 | $4.00 – $4.30 | New |
| Apr 27, 2023 | Diluted earnings per share | FY2023 | $2.11 – $2.41 | New |
| Apr 27, 2023 | Operating income | FY2023 | $134.00M – $145.00M | New |
| Apr 27, 2023 | Operating income | FY2023 | $211.00M – $222.00M | New |
| Apr 27, 2023 | Leverage ratio | FY2023 | 2.5 – 3.5 | New |
| Apr 27, 2023 | GAAP effective tax rate | FY2023 | 15% – 17% | New |
| Apr 27, 2023 | Adjusted effective tax rate | FY2023 | 17% – 19% | New |
| Apr 27, 2023 | Depreciation and amortization | FY2023 | $100.00M – $110.00M | New |
| Apr 27, 2023 | Stock-based compensation | FY2023 | $22.00M – $25.00M | Lowered |
| Apr 27, 2023 | Restructuring, acquisition and other charges | FY2023 | $18.00M – $23.00M | Lowered |
| Apr 27, 2023 | Cash income tax payments | FY2023 | $27.00M – $31.00M | Raised |
| Apr 27, 2023 | Net income | FY2023 | $71.00M – $81.00M | New |
| Apr 27, 2023 | Cash flow from operating activities | FY2023 | $180.00M – $200.00M | Raised |
| Apr 27, 2023 | GAAP total interest expense | FY2023 | $49.00M – $54.00M | Lowered |
| Apr 27, 2023 | Net income | FY2023 | $134.00M – $144.00M | New |
| Apr 27, 2023 | Adjusted total interest expense | FY2023 | $45.00M – $50.00M | Lowered |
| Apr 27, 2023 | Sales | FY2023 | $1.47B – $1.50B | New |
| Oct 27, 2022 | Capital expenditures | FY2022 | $65.00M – $75.00M | Reaffirmed |
| Oct 27, 2022 | EBITDA | FY2022 | $244.00M – $260.00M | Lowered |
| Oct 27, 2022 | Diluted earnings per share | FY2022 | $3.57 – $3.97 | Lowered |
| Oct 27, 2022 | Diluted earnings per share | FY2022 | $1.80 – $2.20 | Lowered |
| Oct 27, 2022 | Operating income | FY2022 | $111.00M – $127.00M | Lowered |
| Oct 27, 2022 | Operating income | FY2022 | $180.00M – $196.00M | Lowered |
| Oct 27, 2022 | Net income | FY2022 | $60.00M – $73.00M | Lowered |
| Oct 27, 2022 | Cash flow from operating activities | FY2022 | $110.00M – $125.00M | Raised |
| Oct 27, 2022 | Net income | FY2022 | $119.00M – $132.00M | Lowered |
| Oct 27, 2022 | Organic sales growth | FY2022 | +4% – +6% | Lowered |
| Oct 27, 2022 | Sales | FY2022 | $1.35B – $1.38B | Lowered |
| Oct 27, 2022 | above-market revenue growth | FY2023 | +7% – +9% | New |
| Jul 28, 2022 | Capital expenditures, net | FY2022 | $65.00M – $75.00M | Reaffirmed |
| Jul 28, 2022 | Adjusted EBITDA | FY2022 | $273.00M – $285.00M | Reaffirmed |
| Jul 28, 2022 | Adjusted diluted earnings per share | FY2022 | $4.20 – $4.50 | Lowered |
| Jul 28, 2022 | Diluted earnings per share | FY2022 | $2.49 – $2.79 | Lowered |
| Jul 28, 2022 | Operating income | FY2022 | $136.00M – $148.00M | Raised |
| Jul 28, 2022 | Adjusted operating income | FY2022 | $206.00M – $218.00M | Raised |
| Jul 28, 2022 | Net income | FY2022 | $83.00M – $93.00M | Lowered |
| Jul 28, 2022 | Cash flow from operating activities | FY2022 | $151.00M – $166.00M | Raised |
| Jul 28, 2022 | Adjusted net income | FY2022 | $140.00M – $151.00M | Lowered |
| Jul 28, 2022 | Organic sales growth | FY2022 | +6% – +8% | Raised |
| Jul 28, 2022 | Sales | FY2022 | $1.37B – $1.40B | Raised |
| Apr 28, 2022 | Capital expenditures, net | FY2022 | $65.00M – $75.00M | Reaffirmed |
| Apr 28, 2022 | EBITDA | FY2022 | $273.00M – $285.00M | Raised |
| Apr 28, 2022 | Adjusted diluted earnings per share | FY2022 | $4.32 – $4.62 | Lowered |
| Apr 28, 2022 | Diluted earnings per share | FY2022 | $2.61 – $2.91 | Lowered |
| Apr 28, 2022 | Operating income | FY2022 | $130.00M – $142.00M | Lowered |
| Apr 28, 2022 | Adjusted operating income | FY2022 | $203.00M – $215.00M | Raised |
| Apr 28, 2022 | organic sales growth | FY2022 | +5% – +7% | New |
| Apr 28, 2022 | Sales | FY2022 | $1.36B – $1.38B | Raised |
| Feb 17, 2022 | Capital expenditures, net | FY2022 | $65.00M – $75.00M | New |
| Feb 17, 2022 | EBITDA | FY2022 | $270.00M – $282.00M | New |
| Feb 17, 2022 | Earnings per Diluted Share | FY2022 | $4.35 – $4.65 | New |
| Feb 17, 2022 | Earnings per Diluted Share | FY2022 | $2.72 – $3.02 | New |
| Feb 17, 2022 | free cash flow | FY2022 | $90.00M – $105.00M | New |
| Feb 17, 2022 | Operating income | FY2022 | $132.00M – $144.00M | New |
| Feb 17, 2022 | Operating income | FY2022 | $201.00M – $213.00M | New |
| Feb 17, 2022 | Net income | FY2022 | $91.00M – $101.00M | New |
| Feb 17, 2022 | Net income | FY2022 | $146.00M – $156.00M | New |
| Feb 17, 2022 | Sales | FY2022 | $1.34B – $1.37B | New |
| Oct 28, 2021 | Capital expenditures, net | FY2021 | $50.00M – $55.00M | New |
| Oct 28, 2021 | Adjusted EBITDA | FY2021 | $245.00M – $255.00M | New |
| Oct 28, 2021 | Adjusted EPS | FY2021 | $3.90 – $4.15 | New |
| Oct 28, 2021 | Diluted earnings per share | FY2021 | $2.69 – $2.94 | New |
| Oct 28, 2021 | free cash flow | FY2021 | $95.00M – $115.00M | New |
| Oct 28, 2021 | Adjusted operating income | FY2021 | $185.00M – $195.00M | New |
| Oct 28, 2021 | Operating income | FY2021 | $136.00M – $146.00M | New |
| Oct 28, 2021 | GAAP interest expense | FY2021 | $31.00M – $32.00M | Lowered |
| Oct 28, 2021 | Adjusted net income | FY2021 | $130.00M – $138.00M | New |
| Oct 28, 2021 | Adjusted interest expense | FY2021 | $27.00M – $28.00M | Lowered |
| Oct 28, 2021 | Cash tax payments | FY2021 | $18.00M – $22.00M | Raised |
| Oct 28, 2021 | GAAP effective tax rate | FY2021 | 9% – 10% | New |
| Oct 28, 2021 | Adjusted effective tax rate | FY2021 | 14.5% – 15.5% | New |
| Oct 28, 2021 | Depreciation and amortization | FY2021 | $80.00M – $85.00M | New |
| Oct 28, 2021 | Stock-based compensation | FY2021 | $16.00M – $17.00M | Lowered |
| Oct 28, 2021 | Other operating expense | FY2021 | $5.00M – $6.00M | Lowered |
| Oct 28, 2021 | Net income | FY2021 | $89.00M – $98.00M | New |
| Oct 28, 2021 | Sales | FY2021 | $1.21B – $1.22B | New |
| Oct 28, 2021 | Sales | FY2021 | $1.21B – $1.22B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Integer filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- News
- News
- News
- Update
- Results
- Results
- Results
- Update
- Results
- News
- Update
- Results
- Results
See a number that looks wrong?